董事介绍
注：董事持股数取自最新公司公告
| 姓名 | 性别 | 职位 | 年龄 | 薪酬 | 持股数(万股) | 截止日期 |
|---|---|---|---|---|---|---|
| Steven Sherman | 男 | Director and Executive Chairman | 75 | 14.27万美元 | 未持股 | 2020-11-05 |
| Marilyn Hamilton | 女 | Director | 75 | 8.44万美元 | 未持股 | 2020-11-05 |
| Jack Peurach | 男 | Director, President and Chief Executive Officer | 54 | 66.06万美元 | 未持股 | 2020-11-05 |
| Ted Wang | 男 | Director | 53 | 7.51万美元 | 未持股 | 2020-11-05 |
| Ted Wang | 男 | Director | 53 | 未披露 | 未持股 | 2020-11-05 |
| Charles Li | 男 | Director | 35 | 8.26万美元 | 未持股 | 2020-11-05 |
| Thomas A. Schreck | -- | Director | -- | 9.18万美元 | 未持股 | 2020-11-05 |
| Stanley Stern | 男 | Director | 63 | 9.54万美元 | 未持股 | 2020-11-05 |
高管介绍
注：高管持股数取自最新公司公告
| 姓名 | 性别 | 职位 | 年龄 | 薪酬 | 持股数(万股) | 截止日期 |
|---|---|---|---|---|---|---|
| Steven Sherman | 男 | Director and Executive Chairman | 75 | 14.27万美元 | 未持股 | 2020-11-05 |
| Jack Peurach | 男 | Director, President and Chief Executive Officer | 54 | 66.06万美元 | 未持股 | 2020-11-05 |
| Jason C. Jones | 男 | Vice President of Product Development | 48 | 31.22万美元 | 未持股 | 2020-11-05 |
| William Shaw | 男 | Chief Commercial Officer | 46 | 未披露 | 未持股 | 2020-11-05 |
| John F. Glenn | 男 | Chief Financial Officer and Secretary | 59 | 39.74万美元 | 未持股 | 2020-11-05 |
董事简历
中英对照 | 中文 | 英文- Steven Sherman
-
Steven Sherman，是公司的董事会主席，也任职于其审计委员会（主席）和薪酬委员会。他也曾任职于Ekso Bionics公司的董事会（自2013年12月以来）。1988年以来，他一直担任Sherman Capital Group（商业银行业务组织，拥有私人和公共投资的投资组合）的成员。除了任职公司，他也是Purple Wave Inc的前任主席。他是Novatel Wireless, Inc.、Vodavi Communications Systems Inc.、Main Street、Main Inc.的创始人。此前，他曾担任Telit的董事、Airlink Communications, Inc.的主席（直到公司出售给Sierra Wireless, Inc）、Executone Information Systems的董事长、Inter-Tel （Delaware） Incorporated的董事。
Steven Sherman has served as our Executive Chairman since October 30 2018. Mr. Sherman Sherman previously served as the Chairman of our Board of Directors since January 2014 and will serve as the Chairman again commencing immediately after the Meeting. He also previously served on the board of directors of Ekso Bionics, Inc., our wholly owned subsidiary, from December 2013 until January 2014. Mr. Sherman is the Chairman of Nex Capital LLC, a private equity firm based in Beverly Hills, California, and he is the Chairman of Imetric, an IOT platform for consumer and enterprise. Since 1988 Mr. Sherman has been a member of Sherman Capital Group, a merchant banking organization with a portfolio of private and public investments. In addition to being our Executive Chairman, Mr. Sherman is the former Chairman of Purple Wave Inc, an online auction platform. Mr. Sherman is a founder of Novatel Wireless, Inc. Nasdaq: NVTL, Vodavi Communications Systems Inc. (Nasdaq: VTEK) and Main Street and Main Inc. Previously, Mr. Sherman has served as a director of Telit; Chairman of Airlink Communications, Inc. until its sale to Sierra Wireless, Inc.; Chairman of Executone Information Systems (Nasdaq NM: XTON); and as a director of Inter-Tel (Delaware) Incorporated (Nasdaq: INTL). - Steven Sherman，是公司的董事会主席，也任职于其审计委员会（主席）和薪酬委员会。他也曾任职于Ekso Bionics公司的董事会（自2013年12月以来）。1988年以来，他一直担任Sherman Capital Group（商业银行业务组织，拥有私人和公共投资的投资组合）的成员。除了任职公司，他也是Purple Wave Inc的前任主席。他是Novatel Wireless, Inc.、Vodavi Communications Systems Inc.、Main Street、Main Inc.的创始人。此前，他曾担任Telit的董事、Airlink Communications, Inc.的主席（直到公司出售给Sierra Wireless, Inc）、Executone Information Systems的董事长、Inter-Tel （Delaware） Incorporated的董事。
- Steven Sherman has served as our Executive Chairman since October 30 2018. Mr. Sherman Sherman previously served as the Chairman of our Board of Directors since January 2014 and will serve as the Chairman again commencing immediately after the Meeting. He also previously served on the board of directors of Ekso Bionics, Inc., our wholly owned subsidiary, from December 2013 until January 2014. Mr. Sherman is the Chairman of Nex Capital LLC, a private equity firm based in Beverly Hills, California, and he is the Chairman of Imetric, an IOT platform for consumer and enterprise. Since 1988 Mr. Sherman has been a member of Sherman Capital Group, a merchant banking organization with a portfolio of private and public investments. In addition to being our Executive Chairman, Mr. Sherman is the former Chairman of Purple Wave Inc, an online auction platform. Mr. Sherman is a founder of Novatel Wireless, Inc. Nasdaq: NVTL, Vodavi Communications Systems Inc. (Nasdaq: VTEK) and Main Street and Main Inc. Previously, Mr. Sherman has served as a director of Telit; Chairman of Airlink Communications, Inc. until its sale to Sierra Wireless, Inc.; Chairman of Executone Information Systems (Nasdaq NM: XTON); and as a director of Inter-Tel (Delaware) Incorporated (Nasdaq: INTL).
- Marilyn Hamilton
-
Marilyn Hamilton，是公司的董事，并任职提名和治理委员会。她也曾任职于Ekso Bionics公司的董事会（自2012年1月以来）。她于2009年创立StimDesigns LLC（神经技术公司，开发设备和分销伽利略神经肌肉康复训练设备），也曾担任首席执行官（2009年至今）。她于2007年创立Envision公司（一个专业演讲和医疗业务咨询公司），也曾担任其首席执行官（2007年至今）。此前，她曾于1979年共同创立Motion Designs Inc.（制造和营销公司，开创了创新的定义、超轻量级的轮椅，引领了整个行业的革命）。她曾担任多种销售、营销和产品开发执行职务，直到公司最终出售给Sunrise Medical Inc.，在那里她曾担任全球副总裁。她于1990年创立Winners on Wheels（儿童轮椅搜索活动）。她于2003年共同创立Discovery through Design，她曾担任女主席，负责提高脊髓损伤研究和妇女健康的意识，以及筹集资金。她曾担任创立理事9年（1994年至2002年），目前担任The California Endowment的荣誉董事会成员。她曾担任美国国立卫生研究院的国家医疗康复研究中心（the National Center for Medical Rehabilitation Research at the National Institute of Health）的咨询委员会成员4年（2010年至2014年）。1993年以来，她一直担任The Committee of 200 business women（使命是培养、庆祝、推进私人和公共公司女性领导）的成员。她持有California Polytechnic State University（位于圣路易斯奥比斯波）的教育和中学教学学士证书。
Marilyn Hamilton is a director of the Company and serves on its Nominating and Governance Committee. She has served on our Board since January 2014 and served on the board of directors of Ekso Bionics, Inc. from September 2011 until January 2014. In 2009 Ms. Hamilton founded StimDesigns LLC, a neurotechnology company that develops devices and distributes Galileo neuromuscular training devices for rehabilitation and has served as CEO from 2009 to present. In 2007 Ms. Hamilton launched Envision, a professional speaking and medical business consulting company, and has served as its CEO from 2007 to present. Prior to this role, Ms. Hamilton co-founded Motion Designs Inc. in 1979 a manufacturing and marketing company that pioneered innovative custom, ultra-lightweight Quickie wheelchairs that revolutionized the industry. She served in various executive roles in sales, marketing and product development at Motion Designs Inc. until it was sold ultimately to Sunrise Medical Inc., where Ms. Hamilton served as Global VP. In 1990 Ms. Hamilton founded Winners on Wheels, a coed-scouting program for children in wheelchairs. In 2003 she co-founded Discovery through Design and served as Chairwoman, raising awareness and funds for spinal cord injury research and women's health. For nine years, from 1994 to 2002 she served as a founding board member and currently serves as emeritus board member of The California Endowment. For four years, from 2010 to 2014 she has served as an advisory board member of the National Center for Medical Rehabilitation Research at the National Institute of Health. Since 1993 Ms. Hamilton has been a member of The Committee of 200 business women whose mission is to foster, celebrate and advance women's leadership in private and public companies. Ms. Hamilton holds a Bachelor of Science in Education and Secondary Teaching Credential from California Polytechnic State University, San Luis Obispo. - Marilyn Hamilton，是公司的董事，并任职提名和治理委员会。她也曾任职于Ekso Bionics公司的董事会（自2012年1月以来）。她于2009年创立StimDesigns LLC（神经技术公司，开发设备和分销伽利略神经肌肉康复训练设备），也曾担任首席执行官（2009年至今）。她于2007年创立Envision公司（一个专业演讲和医疗业务咨询公司），也曾担任其首席执行官（2007年至今）。此前，她曾于1979年共同创立Motion Designs Inc.（制造和营销公司，开创了创新的定义、超轻量级的轮椅，引领了整个行业的革命）。她曾担任多种销售、营销和产品开发执行职务，直到公司最终出售给Sunrise Medical Inc.，在那里她曾担任全球副总裁。她于1990年创立Winners on Wheels（儿童轮椅搜索活动）。她于2003年共同创立Discovery through Design，她曾担任女主席，负责提高脊髓损伤研究和妇女健康的意识，以及筹集资金。她曾担任创立理事9年（1994年至2002年），目前担任The California Endowment的荣誉董事会成员。她曾担任美国国立卫生研究院的国家医疗康复研究中心（the National Center for Medical Rehabilitation Research at the National Institute of Health）的咨询委员会成员4年（2010年至2014年）。1993年以来，她一直担任The Committee of 200 business women（使命是培养、庆祝、推进私人和公共公司女性领导）的成员。她持有California Polytechnic State University（位于圣路易斯奥比斯波）的教育和中学教学学士证书。
- Marilyn Hamilton is a director of the Company and serves on its Nominating and Governance Committee. She has served on our Board since January 2014 and served on the board of directors of Ekso Bionics, Inc. from September 2011 until January 2014. In 2009 Ms. Hamilton founded StimDesigns LLC, a neurotechnology company that develops devices and distributes Galileo neuromuscular training devices for rehabilitation and has served as CEO from 2009 to present. In 2007 Ms. Hamilton launched Envision, a professional speaking and medical business consulting company, and has served as its CEO from 2007 to present. Prior to this role, Ms. Hamilton co-founded Motion Designs Inc. in 1979 a manufacturing and marketing company that pioneered innovative custom, ultra-lightweight Quickie wheelchairs that revolutionized the industry. She served in various executive roles in sales, marketing and product development at Motion Designs Inc. until it was sold ultimately to Sunrise Medical Inc., where Ms. Hamilton served as Global VP. In 1990 Ms. Hamilton founded Winners on Wheels, a coed-scouting program for children in wheelchairs. In 2003 she co-founded Discovery through Design and served as Chairwoman, raising awareness and funds for spinal cord injury research and women's health. For nine years, from 1994 to 2002 she served as a founding board member and currently serves as emeritus board member of The California Endowment. For four years, from 2010 to 2014 she has served as an advisory board member of the National Center for Medical Rehabilitation Research at the National Institute of Health. Since 1993 Ms. Hamilton has been a member of The Committee of 200 business women whose mission is to foster, celebrate and advance women's leadership in private and public companies. Ms. Hamilton holds a Bachelor of Science in Education and Secondary Teaching Credential from California Polytechnic State University, San Luis Obispo.
- Jack Peurach
-
Jack Peurach，是公司的董事，并担任薪酬委员会主席，也任职其提名和治理委员会。他也曾任职于Ekso Bionics公司的董事会（自2012年1月以来）。2011年以来，他一直担任SunPower Corp （NASDAQ：SPWR）的产品执行副总裁，在那里他负责SunPower公司的光伏模块和住宅、商业和实用光伏系统的所有层面。2009年至2011年，他曾担任SunPower公司的研发执行副总裁，在那里他曾领导光伏电池、模块和系统的研发职务。2008年至2009年，他曾担任高级产品开发集团的副总裁。2007年至2008年，他曾担任SunPower公司的高级产品开发主管。2007年SunPower公司收购PowerLight公司之前，他曾担任PowerLight公司的产品开发副总裁。职业生涯早期，他曾担任Mercer Management Consulting的战略顾问，以及Berkeley Process Control, Inc的工程董事。他持有Michigan State University的机械工程科学学士学位、加州大学伯克利分校（the University of California, Berkeley）的机械工程科学硕士学位、宾夕法尼亚大学沃顿商学院（the Wharton School, University of Pennsylvania）的工商管理学、金融和创业精神硕士学位。
Jack Peurach is our President and Chief Executive Officer and a member of our Board of Directors. Mr. Peurach was appointed as our President and Chief Executive Officer on March 9 2018. Prior to his appointment as our President and Chief Executive Officer, Mr. Peurach served as a director, the Chairman of the Compensation Committee of our Board of Directors and as a member of the Nominating and Governance Committee and the Audit Committee of our Board of Directors. Mr. Peurach served on the board of directors of Ekso Bionics, Inc., which merged with our wholly-owned subsidiary in January 2014 and continued as the surviving entity in the merger, from July 2011 until the merger, and has served on our Board of Directors since the merger. From 2011 to March 2017 Mr. Peurach served as the Executive Vice President, Products for SunPower Corp Nasdaq: SPWR, where he was responsible for all aspects of SunPower’s PV modules and residential, commercial and utility PV systems. Prior to this role, from 2009 to 2011 Mr. Peurach served as Executive Vice President, Research and Development for SunPower, where he led the research and development efforts of the PV Cells, Modules and Systems. From 2008 to 2009 Mr. Peurach was the Vice President of the Advanced Product Development Group, and from 2007 to 2008 Mr. Peurach was the Senior Director of Product Development at SunPower. Prior to SunPower’s acquisition of PowerLight in 2007 Mr. Peurach served as PowerLight’s Vice President of Product Development. Earlier in his career, Mr. Peurach was a strategy consultant for Mercer Management Consulting and director of engineering at Berkeley Process Control, Inc. Mr. Peurach also serves as a director of MyCore Health, Inc. Mr. Peurach holds a Bachelor of Science degree in Mechanical Engineering from Michigan State University, a Master of Science degree in Mechanical Engineering from the University of California, Berkeley, and a Master of Business Administration, Finance and Entrepreneurship from the Wharton School, University of Pennsylvania. - Jack Peurach，是公司的董事，并担任薪酬委员会主席，也任职其提名和治理委员会。他也曾任职于Ekso Bionics公司的董事会（自2012年1月以来）。2011年以来，他一直担任SunPower Corp （NASDAQ：SPWR）的产品执行副总裁，在那里他负责SunPower公司的光伏模块和住宅、商业和实用光伏系统的所有层面。2009年至2011年，他曾担任SunPower公司的研发执行副总裁，在那里他曾领导光伏电池、模块和系统的研发职务。2008年至2009年，他曾担任高级产品开发集团的副总裁。2007年至2008年，他曾担任SunPower公司的高级产品开发主管。2007年SunPower公司收购PowerLight公司之前，他曾担任PowerLight公司的产品开发副总裁。职业生涯早期，他曾担任Mercer Management Consulting的战略顾问，以及Berkeley Process Control, Inc的工程董事。他持有Michigan State University的机械工程科学学士学位、加州大学伯克利分校（the University of California, Berkeley）的机械工程科学硕士学位、宾夕法尼亚大学沃顿商学院（the Wharton School, University of Pennsylvania）的工商管理学、金融和创业精神硕士学位。
- Jack Peurach is our President and Chief Executive Officer and a member of our Board of Directors. Mr. Peurach was appointed as our President and Chief Executive Officer on March 9 2018. Prior to his appointment as our President and Chief Executive Officer, Mr. Peurach served as a director, the Chairman of the Compensation Committee of our Board of Directors and as a member of the Nominating and Governance Committee and the Audit Committee of our Board of Directors. Mr. Peurach served on the board of directors of Ekso Bionics, Inc., which merged with our wholly-owned subsidiary in January 2014 and continued as the surviving entity in the merger, from July 2011 until the merger, and has served on our Board of Directors since the merger. From 2011 to March 2017 Mr. Peurach served as the Executive Vice President, Products for SunPower Corp Nasdaq: SPWR, where he was responsible for all aspects of SunPower’s PV modules and residential, commercial and utility PV systems. Prior to this role, from 2009 to 2011 Mr. Peurach served as Executive Vice President, Research and Development for SunPower, where he led the research and development efforts of the PV Cells, Modules and Systems. From 2008 to 2009 Mr. Peurach was the Vice President of the Advanced Product Development Group, and from 2007 to 2008 Mr. Peurach was the Senior Director of Product Development at SunPower. Prior to SunPower’s acquisition of PowerLight in 2007 Mr. Peurach served as PowerLight’s Vice President of Product Development. Earlier in his career, Mr. Peurach was a strategy consultant for Mercer Management Consulting and director of engineering at Berkeley Process Control, Inc. Mr. Peurach also serves as a director of MyCore Health, Inc. Mr. Peurach holds a Bachelor of Science degree in Mechanical Engineering from Michigan State University, a Master of Science degree in Mechanical Engineering from the University of California, Berkeley, and a Master of Business Administration, Finance and Entrepreneurship from the Wharton School, University of Pennsylvania.
- Ted Wang
-
Ted Wang自2017年11月起担任董事会成员。Wang博士自2015年1月起担任Puissence Capital Management LP的首席投资官，他是该公司的创始人。在此之前，Wang博士是高盛（Goldman，Sachs&Co。）的合伙人，他于1996年加入高盛（Goldman），并担任过许多领导职务，最近主要是担任美国股票交易联席主管和One Delta Trading全球联席主管，以及高盛风险委员会（Goldman Sachs Risk Committee）成员。在加入高盛之前，Wang博士在德克萨斯州共同创立了Xeotron公司，这是一家专门生产DNA生物芯片的公司。Wang博士是Ekso Bionics Holdings，Inc.，Viewray，Inc。和Tracon Pharmaceuticals，Inc。董事会成员。Wang博士拥有明尼苏达大学物理学博士学位、奥斯汀德克萨斯大学工商管理硕士学位和中国复旦大学理学学士学位。
Ted Wang has served as a member of our Board since November 2017. Dr. Wang has served as the Chief Investment Officer of Puissance Capital Management LP, of which he was a founder, since January 2015. Prior to that, Dr. Wang was a Partner of Goldman, Sachs & Co. ("Goldman"), which he joined in 1996 and with which he served in many leadership positions, mostly recently as Co-Head of U.S. Equities Trading and Global Co-Head of One Delta Trading and a member of the Goldman Sachs Risk Committee. Prior to joining Goldman, Dr. Wang co-founded Xeotron Corp., a company specializing in DNA biochips in Texas. Dr. Wang serves on the board of Ekso Bionics Holdings, Inc., Viewray, Inc. and Tracon Pharmaceuticals, Inc. Dr. Wang holds a Ph.D. in Physics from the University of Minnesota, an M.B.A. from the University of Texas, Austin, and a B.S. from Fudan University, China. - Ted Wang自2017年11月起担任董事会成员。Wang博士自2015年1月起担任Puissence Capital Management LP的首席投资官，他是该公司的创始人。在此之前，Wang博士是高盛（Goldman，Sachs&Co。）的合伙人，他于1996年加入高盛（Goldman），并担任过许多领导职务，最近主要是担任美国股票交易联席主管和One Delta Trading全球联席主管，以及高盛风险委员会（Goldman Sachs Risk Committee）成员。在加入高盛之前，Wang博士在德克萨斯州共同创立了Xeotron公司，这是一家专门生产DNA生物芯片的公司。Wang博士是Ekso Bionics Holdings，Inc.，Viewray，Inc。和Tracon Pharmaceuticals，Inc。董事会成员。Wang博士拥有明尼苏达大学物理学博士学位、奥斯汀德克萨斯大学工商管理硕士学位和中国复旦大学理学学士学位。
- Ted Wang has served as a member of our Board since November 2017. Dr. Wang has served as the Chief Investment Officer of Puissance Capital Management LP, of which he was a founder, since January 2015. Prior to that, Dr. Wang was a Partner of Goldman, Sachs & Co. ("Goldman"), which he joined in 1996 and with which he served in many leadership positions, mostly recently as Co-Head of U.S. Equities Trading and Global Co-Head of One Delta Trading and a member of the Goldman Sachs Risk Committee. Prior to joining Goldman, Dr. Wang co-founded Xeotron Corp., a company specializing in DNA biochips in Texas. Dr. Wang serves on the board of Ekso Bionics Holdings, Inc., Viewray, Inc. and Tracon Pharmaceuticals, Inc. Dr. Wang holds a Ph.D. in Physics from the University of Minnesota, an M.B.A. from the University of Texas, Austin, and a B.S. from Fudan University, China.
- Ted Wang
-
暂无中文简介
Ted Wang is a member of our Board of Directors. He has served on our Board of Directors since September 2017. Dr. Wang has served as the Chief Investment Officer of Puissance Capital Management LP “Puissance Capital”, of which he was a founder, since January 2015. Prior to that, Dr. Wang was a Partner of Goldman, Sachs & Co. (“Goldman”), which he joined in 1996 and with which he served in many leadership positions, mostly recently as Co-Head of U.S. Equities Trading and Global Co-Head of One Delta Trading and a member of the Goldman Sachs Risk Committee. Prior to joining Goldman, Dr. Wang co-founded Xeotron Corp., a company specializing in DNA biochips in Texas. Dr. Wang is currently a director at the following public companies: Bellerophon Therapeutics, Inc. (Nasdaq: BLPH), ViewRay, Inc. (Nasdaq: VRAY), and Fiduciary Trust Company International (NYSE: BEN). Dr. Wang holds a Ph.D. in Physics from the University of Minnesota, an M.B.A. from the University of Texas, Austin, and a B.S. from Fudan University, China. -
暂无中文简介
- Ted Wang is a member of our Board of Directors. He has served on our Board of Directors since September 2017. Dr. Wang has served as the Chief Investment Officer of Puissance Capital Management LP “Puissance Capital”, of which he was a founder, since January 2015. Prior to that, Dr. Wang was a Partner of Goldman, Sachs & Co. (“Goldman”), which he joined in 1996 and with which he served in many leadership positions, mostly recently as Co-Head of U.S. Equities Trading and Global Co-Head of One Delta Trading and a member of the Goldman Sachs Risk Committee. Prior to joining Goldman, Dr. Wang co-founded Xeotron Corp., a company specializing in DNA biochips in Texas. Dr. Wang is currently a director at the following public companies: Bellerophon Therapeutics, Inc. (Nasdaq: BLPH), ViewRay, Inc. (Nasdaq: VRAY), and Fiduciary Trust Company International (NYSE: BEN). Dr. Wang holds a Ph.D. in Physics from the University of Minnesota, an M.B.A. from the University of Texas, Austin, and a B.S. from Fudan University, China.
- Charles Li
-
Charles Li是我们董事会的成员，并任职于我们董事会的审计委员会以及提名和公司治理委员会。自2018年3月以来，他一直担任我们的董事会成员。李博士自2015年以来一直担任Puissance Capital的高级分析师，并参与了Puissance Capital的许多投资。在加入Puissance Capital之前，李博士于2011年至2015年在哈佛大学担任研究助理。李博士还于2009年在复星资本担任分析师，并于2010年在嘉实基金担任分析师。李博士在哈佛大学JohnA.Paulson工程与应用科学学院获得博士学位，并在中国西安交通大学获得文学学士和文学学士学位。
Charles Li is a member of our Board of Directors and serves on the Audit Committee and the Nominating and Corporate Governance Committee of our Board of Directors. He has served on our Board of Directors since March 2018. Dr. Li has been a senior analyst at Puissance Capital since 2015 and has been involved in many of Puissance Capital’s investments. Prior to joining Puissance Capital, Dr. Li worked as a Research Assistant at Harvard University from 2011 to 2015. Dr. Li also worked as an analyst at Fosun Capital in 2009 and at Harvest Fund in 2010. Dr. Li received his Ph.D. from the John A. Paulson School of Engineering and Applied Sciences from Harvard University, and a B.S. and B.A. from Xi’an Jiaotong University in Xi’an, China. - Charles Li是我们董事会的成员，并任职于我们董事会的审计委员会以及提名和公司治理委员会。自2018年3月以来，他一直担任我们的董事会成员。李博士自2015年以来一直担任Puissance Capital的高级分析师，并参与了Puissance Capital的许多投资。在加入Puissance Capital之前，李博士于2011年至2015年在哈佛大学担任研究助理。李博士还于2009年在复星资本担任分析师，并于2010年在嘉实基金担任分析师。李博士在哈佛大学JohnA.Paulson工程与应用科学学院获得博士学位，并在中国西安交通大学获得文学学士和文学学士学位。
- Charles Li is a member of our Board of Directors and serves on the Audit Committee and the Nominating and Corporate Governance Committee of our Board of Directors. He has served on our Board of Directors since March 2018. Dr. Li has been a senior analyst at Puissance Capital since 2015 and has been involved in many of Puissance Capital’s investments. Prior to joining Puissance Capital, Dr. Li worked as a Research Assistant at Harvard University from 2011 to 2015. Dr. Li also worked as an analyst at Fosun Capital in 2009 and at Harvest Fund in 2010. Dr. Li received his Ph.D. from the John A. Paulson School of Engineering and Applied Sciences from Harvard University, and a B.S. and B.A. from Xi’an Jiaotong University in Xi’an, China.
- Thomas A. Schreck
-
暂无中文简介
暂无英文简介 -
暂无中文简介
- 暂无英文简介
- Stanley Stern
-
Stanley Stern自2003年7月以来担任Fundtech的董事。自2004年以来他担任纽约州纽约的Oppenheimer & Co. Inc.的技术业务主管。加入Oppenheimer & Co. Inc.之前，他从2002年到2004年担任纽约州纽约的C.E. Unterberg, Towbin投资银行业务的主管。加入C.E. Unterberg, Towbin之前，从2000年到2003年他担任美国（the U.S.A.）的董事总经理和STI Ventures（全球性的风险资本公司）的董事会和投资委员会成员。从1981年到2000年他是Oppenheimer & Co., Inc.和CIBC/Oppenheimer的合伙人，担任许多角色包括科技投资银行业务的主管。他担任Tucows, Inc.的董事会主席。他获得哈佛大学商学院（Harvard University Graduate School of Business）和纽约城市大学（City University of New York）的学位。
Stanley Stern is a member of our Board of Directors and serves as the Chair of the Audit Committee of our Board of Directors. He has served on our Board of Directors since December 2014. He currently is Managing Partner of Alnitak Capital, which he founded in 2013 to provide Board level strategic advisory services, primarily in technology related industries. Before founding Alnitak, Mr. Stern was a Managing Director at Oppenheimer & Co. NYSE: OPY from 1982 to 2000 and from 2004 to 2013 where, among other positions, he led the firm’s investment banking department and technology investment banking groups. Mr. Stern also held roles at Salomon Brothers, STI Ventures and C.E. Unterberg. Mr. Stern is currently the Chairman of the Board of Audiocodes Inc. (Nasdaq: AUDC), a leader in VOIP infrastructure equipment, a Board member of Ormat Technologies (NYSE: ORA), a global leader in geothermal energy, and a Board member of Tigo Energy, a solar energy equipment supplier. Previously, Mr. Stern was chairman of the board of directors of Sodastream (Nasdaq: SODA), the global leader of at home beverage makers, a member of the board of directors of Foamix Pharmaceuticals Ltd. (Nasdaq: FOMX), a member of the board of directors of Given Imaging (Nasdaq: GIVN), a member of the board of directors of Fundtech Inc., and chairman of the board of directors of Tucows, Inc. (Nasdaq: TCX). Mr. Stern holds a Bachelor of Arts in Economics and Accounting from City University of New York, Queens College, and a Master of Business Administration from Harvard University. - Stanley Stern自2003年7月以来担任Fundtech的董事。自2004年以来他担任纽约州纽约的Oppenheimer & Co. Inc.的技术业务主管。加入Oppenheimer & Co. Inc.之前，他从2002年到2004年担任纽约州纽约的C.E. Unterberg, Towbin投资银行业务的主管。加入C.E. Unterberg, Towbin之前，从2000年到2003年他担任美国（the U.S.A.）的董事总经理和STI Ventures（全球性的风险资本公司）的董事会和投资委员会成员。从1981年到2000年他是Oppenheimer & Co., Inc.和CIBC/Oppenheimer的合伙人，担任许多角色包括科技投资银行业务的主管。他担任Tucows, Inc.的董事会主席。他获得哈佛大学商学院（Harvard University Graduate School of Business）和纽约城市大学（City University of New York）的学位。
- Stanley Stern is a member of our Board of Directors and serves as the Chair of the Audit Committee of our Board of Directors. He has served on our Board of Directors since December 2014. He currently is Managing Partner of Alnitak Capital, which he founded in 2013 to provide Board level strategic advisory services, primarily in technology related industries. Before founding Alnitak, Mr. Stern was a Managing Director at Oppenheimer & Co. NYSE: OPY from 1982 to 2000 and from 2004 to 2013 where, among other positions, he led the firm’s investment banking department and technology investment banking groups. Mr. Stern also held roles at Salomon Brothers, STI Ventures and C.E. Unterberg. Mr. Stern is currently the Chairman of the Board of Audiocodes Inc. (Nasdaq: AUDC), a leader in VOIP infrastructure equipment, a Board member of Ormat Technologies (NYSE: ORA), a global leader in geothermal energy, and a Board member of Tigo Energy, a solar energy equipment supplier. Previously, Mr. Stern was chairman of the board of directors of Sodastream (Nasdaq: SODA), the global leader of at home beverage makers, a member of the board of directors of Foamix Pharmaceuticals Ltd. (Nasdaq: FOMX), a member of the board of directors of Given Imaging (Nasdaq: GIVN), a member of the board of directors of Fundtech Inc., and chairman of the board of directors of Tucows, Inc. (Nasdaq: TCX). Mr. Stern holds a Bachelor of Arts in Economics and Accounting from City University of New York, Queens College, and a Master of Business Administration from Harvard University.
高管简历
中英对照 | 中文 | 英文- Steven Sherman
Steven Sherman，是公司的董事会主席，也任职于其审计委员会（主席）和薪酬委员会。他也曾任职于Ekso Bionics公司的董事会（自2013年12月以来）。1988年以来，他一直担任Sherman Capital Group（商业银行业务组织，拥有私人和公共投资的投资组合）的成员。除了任职公司，他也是Purple Wave Inc的前任主席。他是Novatel Wireless, Inc.、Vodavi Communications Systems Inc.、Main Street、Main Inc.的创始人。此前，他曾担任Telit的董事、Airlink Communications, Inc.的主席（直到公司出售给Sierra Wireless, Inc）、Executone Information Systems的董事长、Inter-Tel （Delaware） Incorporated的董事。
Steven Sherman has served as our Executive Chairman since October 30 2018. Mr. Sherman Sherman previously served as the Chairman of our Board of Directors since January 2014 and will serve as the Chairman again commencing immediately after the Meeting. He also previously served on the board of directors of Ekso Bionics, Inc., our wholly owned subsidiary, from December 2013 until January 2014. Mr. Sherman is the Chairman of Nex Capital LLC, a private equity firm based in Beverly Hills, California, and he is the Chairman of Imetric, an IOT platform for consumer and enterprise. Since 1988 Mr. Sherman has been a member of Sherman Capital Group, a merchant banking organization with a portfolio of private and public investments. In addition to being our Executive Chairman, Mr. Sherman is the former Chairman of Purple Wave Inc, an online auction platform. Mr. Sherman is a founder of Novatel Wireless, Inc. Nasdaq: NVTL, Vodavi Communications Systems Inc. (Nasdaq: VTEK) and Main Street and Main Inc. Previously, Mr. Sherman has served as a director of Telit; Chairman of Airlink Communications, Inc. until its sale to Sierra Wireless, Inc.; Chairman of Executone Information Systems (Nasdaq NM: XTON); and as a director of Inter-Tel (Delaware) Incorporated (Nasdaq: INTL).- Steven Sherman，是公司的董事会主席，也任职于其审计委员会（主席）和薪酬委员会。他也曾任职于Ekso Bionics公司的董事会（自2013年12月以来）。1988年以来，他一直担任Sherman Capital Group（商业银行业务组织，拥有私人和公共投资的投资组合）的成员。除了任职公司，他也是Purple Wave Inc的前任主席。他是Novatel Wireless, Inc.、Vodavi Communications Systems Inc.、Main Street、Main Inc.的创始人。此前，他曾担任Telit的董事、Airlink Communications, Inc.的主席（直到公司出售给Sierra Wireless, Inc）、Executone Information Systems的董事长、Inter-Tel （Delaware） Incorporated的董事。
- Steven Sherman has served as our Executive Chairman since October 30 2018. Mr. Sherman Sherman previously served as the Chairman of our Board of Directors since January 2014 and will serve as the Chairman again commencing immediately after the Meeting. He also previously served on the board of directors of Ekso Bionics, Inc., our wholly owned subsidiary, from December 2013 until January 2014. Mr. Sherman is the Chairman of Nex Capital LLC, a private equity firm based in Beverly Hills, California, and he is the Chairman of Imetric, an IOT platform for consumer and enterprise. Since 1988 Mr. Sherman has been a member of Sherman Capital Group, a merchant banking organization with a portfolio of private and public investments. In addition to being our Executive Chairman, Mr. Sherman is the former Chairman of Purple Wave Inc, an online auction platform. Mr. Sherman is a founder of Novatel Wireless, Inc. Nasdaq: NVTL, Vodavi Communications Systems Inc. (Nasdaq: VTEK) and Main Street and Main Inc. Previously, Mr. Sherman has served as a director of Telit; Chairman of Airlink Communications, Inc. until its sale to Sierra Wireless, Inc.; Chairman of Executone Information Systems (Nasdaq NM: XTON); and as a director of Inter-Tel (Delaware) Incorporated (Nasdaq: INTL).
- Jack Peurach
Jack Peurach，是公司的董事，并担任薪酬委员会主席，也任职其提名和治理委员会。他也曾任职于Ekso Bionics公司的董事会（自2012年1月以来）。2011年以来，他一直担任SunPower Corp （NASDAQ：SPWR）的产品执行副总裁，在那里他负责SunPower公司的光伏模块和住宅、商业和实用光伏系统的所有层面。2009年至2011年，他曾担任SunPower公司的研发执行副总裁，在那里他曾领导光伏电池、模块和系统的研发职务。2008年至2009年，他曾担任高级产品开发集团的副总裁。2007年至2008年，他曾担任SunPower公司的高级产品开发主管。2007年SunPower公司收购PowerLight公司之前，他曾担任PowerLight公司的产品开发副总裁。职业生涯早期，他曾担任Mercer Management Consulting的战略顾问，以及Berkeley Process Control, Inc的工程董事。他持有Michigan State University的机械工程科学学士学位、加州大学伯克利分校（the University of California, Berkeley）的机械工程科学硕士学位、宾夕法尼亚大学沃顿商学院（the Wharton School, University of Pennsylvania）的工商管理学、金融和创业精神硕士学位。
Jack Peurach is our President and Chief Executive Officer and a member of our Board of Directors. Mr. Peurach was appointed as our President and Chief Executive Officer on March 9 2018. Prior to his appointment as our President and Chief Executive Officer, Mr. Peurach served as a director, the Chairman of the Compensation Committee of our Board of Directors and as a member of the Nominating and Governance Committee and the Audit Committee of our Board of Directors. Mr. Peurach served on the board of directors of Ekso Bionics, Inc., which merged with our wholly-owned subsidiary in January 2014 and continued as the surviving entity in the merger, from July 2011 until the merger, and has served on our Board of Directors since the merger. From 2011 to March 2017 Mr. Peurach served as the Executive Vice President, Products for SunPower Corp Nasdaq: SPWR, where he was responsible for all aspects of SunPower’s PV modules and residential, commercial and utility PV systems. Prior to this role, from 2009 to 2011 Mr. Peurach served as Executive Vice President, Research and Development for SunPower, where he led the research and development efforts of the PV Cells, Modules and Systems. From 2008 to 2009 Mr. Peurach was the Vice President of the Advanced Product Development Group, and from 2007 to 2008 Mr. Peurach was the Senior Director of Product Development at SunPower. Prior to SunPower’s acquisition of PowerLight in 2007 Mr. Peurach served as PowerLight’s Vice President of Product Development. Earlier in his career, Mr. Peurach was a strategy consultant for Mercer Management Consulting and director of engineering at Berkeley Process Control, Inc. Mr. Peurach also serves as a director of MyCore Health, Inc. Mr. Peurach holds a Bachelor of Science degree in Mechanical Engineering from Michigan State University, a Master of Science degree in Mechanical Engineering from the University of California, Berkeley, and a Master of Business Administration, Finance and Entrepreneurship from the Wharton School, University of Pennsylvania.- Jack Peurach，是公司的董事，并担任薪酬委员会主席，也任职其提名和治理委员会。他也曾任职于Ekso Bionics公司的董事会（自2012年1月以来）。2011年以来，他一直担任SunPower Corp （NASDAQ：SPWR）的产品执行副总裁，在那里他负责SunPower公司的光伏模块和住宅、商业和实用光伏系统的所有层面。2009年至2011年，他曾担任SunPower公司的研发执行副总裁，在那里他曾领导光伏电池、模块和系统的研发职务。2008年至2009年，他曾担任高级产品开发集团的副总裁。2007年至2008年，他曾担任SunPower公司的高级产品开发主管。2007年SunPower公司收购PowerLight公司之前，他曾担任PowerLight公司的产品开发副总裁。职业生涯早期，他曾担任Mercer Management Consulting的战略顾问，以及Berkeley Process Control, Inc的工程董事。他持有Michigan State University的机械工程科学学士学位、加州大学伯克利分校（the University of California, Berkeley）的机械工程科学硕士学位、宾夕法尼亚大学沃顿商学院（the Wharton School, University of Pennsylvania）的工商管理学、金融和创业精神硕士学位。
- Jack Peurach is our President and Chief Executive Officer and a member of our Board of Directors. Mr. Peurach was appointed as our President and Chief Executive Officer on March 9 2018. Prior to his appointment as our President and Chief Executive Officer, Mr. Peurach served as a director, the Chairman of the Compensation Committee of our Board of Directors and as a member of the Nominating and Governance Committee and the Audit Committee of our Board of Directors. Mr. Peurach served on the board of directors of Ekso Bionics, Inc., which merged with our wholly-owned subsidiary in January 2014 and continued as the surviving entity in the merger, from July 2011 until the merger, and has served on our Board of Directors since the merger. From 2011 to March 2017 Mr. Peurach served as the Executive Vice President, Products for SunPower Corp Nasdaq: SPWR, where he was responsible for all aspects of SunPower’s PV modules and residential, commercial and utility PV systems. Prior to this role, from 2009 to 2011 Mr. Peurach served as Executive Vice President, Research and Development for SunPower, where he led the research and development efforts of the PV Cells, Modules and Systems. From 2008 to 2009 Mr. Peurach was the Vice President of the Advanced Product Development Group, and from 2007 to 2008 Mr. Peurach was the Senior Director of Product Development at SunPower. Prior to SunPower’s acquisition of PowerLight in 2007 Mr. Peurach served as PowerLight’s Vice President of Product Development. Earlier in his career, Mr. Peurach was a strategy consultant for Mercer Management Consulting and director of engineering at Berkeley Process Control, Inc. Mr. Peurach also serves as a director of MyCore Health, Inc. Mr. Peurach holds a Bachelor of Science degree in Mechanical Engineering from Michigan State University, a Master of Science degree in Mechanical Engineering from the University of California, Berkeley, and a Master of Business Administration, Finance and Entrepreneurship from the Wharton School, University of Pennsylvania.
- Jason C. Jones
Jason C.Jones是我们产品开发的Vice President自2018年10月以来，琼斯先生一直领导我们的工程和产品管理集团，重点是扩大我们在医疗和工业市场的市场领先地位。在加入我们之前，琼斯先生于2010年至2018年担任Berkeley Renewables LLC的创始人兼负责人，该公司是一家合同产品开发咨询公司，主要致力于太阳能行业的新型监控系统。Jones先生于2007年共同创立，运营并最终出售了Tilt Solar LLC，该公司是一家为太阳能行业开发技术和设备的初创公司。由于Tilt Solar的出售，Jones先生担任Sunpower Corporation（Nasdaq:SPWR）公用事业产品线经理，直到2010年。从2004年到2013年，Jones先生还在多家投资银行担任了五年的技术部门的股票研究分析师，包括美国银行（NYSE:BAC）和Citadel Securities（ASX:CGL）。在他的早期职业生涯中，Jones先生在工业自动化和机器人领域担任系统工程师。Jones先生持有加州大学伯克利分校（University of California，Berkeley）机械工程理学学士学位，加州大学伯克利分校（University of California，Berkeley）机械工程理学硕士学位和工商管理硕士学位，重点是金融和创业，来自加州大学伯克利分校哈斯商学院。
Jason C. Jones is our Vice President of Product Development. Since October 2018 Mr. Jones has led our Engineering and Product Management groups with an emphasis on extending our market leading position in both medical and industrial markets. Prior to joining us, from 2010 to 2018 Mr. Jones served as Founder and Principal at Berkeley Renewables LLC, a contract product development consulting firm focused on novel monitoring and control systems primarily for the solar industry. In 2007 Mr. Jones co-founded, operated, and ultimately sold Tilt Solar LLC, a startup that developed technology and equipment for the solar industry. As a result of the Tilt Solar sale, Mr. Jones served as Product Line Manager for Utilities at SunPower Corporation Nasdaq: SPWR until 2010. From 2004 to 2013 Mr. Jones also spent a total of five years working as an Equity Research Analyst in the technology sector at multiple investment banks, including Bank of America (NYSE: BAC) and Citadel Securities (ASX: CGL). In his early career, Mr. Jones worked as a Systems Engineer in industrial automation and robotics. Mr. Jones holds a Bachelor of Science degree in Mechanical Engineering from the University of California, Berkeley, a Master of Science degree in Mechanical Engineering from the University of California, Berkeley, and a Master of Business Administration, with an emphasis on finance and entrepreneurship, from the Haas School of Business at the University of California, Berkeley.- Jason C.Jones是我们产品开发的Vice President自2018年10月以来，琼斯先生一直领导我们的工程和产品管理集团，重点是扩大我们在医疗和工业市场的市场领先地位。在加入我们之前，琼斯先生于2010年至2018年担任Berkeley Renewables LLC的创始人兼负责人，该公司是一家合同产品开发咨询公司，主要致力于太阳能行业的新型监控系统。Jones先生于2007年共同创立，运营并最终出售了Tilt Solar LLC，该公司是一家为太阳能行业开发技术和设备的初创公司。由于Tilt Solar的出售，Jones先生担任Sunpower Corporation（Nasdaq:SPWR）公用事业产品线经理，直到2010年。从2004年到2013年，Jones先生还在多家投资银行担任了五年的技术部门的股票研究分析师，包括美国银行（NYSE:BAC）和Citadel Securities（ASX:CGL）。在他的早期职业生涯中，Jones先生在工业自动化和机器人领域担任系统工程师。Jones先生持有加州大学伯克利分校（University of California，Berkeley）机械工程理学学士学位，加州大学伯克利分校（University of California，Berkeley）机械工程理学硕士学位和工商管理硕士学位，重点是金融和创业，来自加州大学伯克利分校哈斯商学院。
- Jason C. Jones is our Vice President of Product Development. Since October 2018 Mr. Jones has led our Engineering and Product Management groups with an emphasis on extending our market leading position in both medical and industrial markets. Prior to joining us, from 2010 to 2018 Mr. Jones served as Founder and Principal at Berkeley Renewables LLC, a contract product development consulting firm focused on novel monitoring and control systems primarily for the solar industry. In 2007 Mr. Jones co-founded, operated, and ultimately sold Tilt Solar LLC, a startup that developed technology and equipment for the solar industry. As a result of the Tilt Solar sale, Mr. Jones served as Product Line Manager for Utilities at SunPower Corporation Nasdaq: SPWR until 2010. From 2004 to 2013 Mr. Jones also spent a total of five years working as an Equity Research Analyst in the technology sector at multiple investment banks, including Bank of America (NYSE: BAC) and Citadel Securities (ASX: CGL). In his early career, Mr. Jones worked as a Systems Engineer in industrial automation and robotics. Mr. Jones holds a Bachelor of Science degree in Mechanical Engineering from the University of California, Berkeley, a Master of Science degree in Mechanical Engineering from the University of California, Berkeley, and a Master of Business Administration, with an emphasis on finance and entrepreneurship, from the Haas School of Business at the University of California, Berkeley.
- William Shaw
William Shaw是我们的首席商务官，自2019年5月6日起担任该职位。从2014年7月到加入公司，Shaw先生在Zimmer Biomet Robotics NYSE:ZBH（前身为Medtech Surgical Inc.）担任不同职位，该公司是一家肌肉骨骼产品制造商，最近担任Rosa Robotics平台和Zimmer Biomet MyMobility的美洲商业Vice President。在那个职位上，Shaw先生的职责包括管理新的战略业务单元和为业务单元建立新的企业培训组织。从2014年2月到2014年7月，他曾担任Salesforce.com公司（纽约证券交易所代码:CRM）（基于云的软件即服务公司）的区域销售董事，在那里他曾管理中部地区小企业团队。
William Shaw is our Chief Commercial Officer, and he has served in that position since May 6 2019. From July 2014 until joining the Company, Mr. Shaw worked in different roles at Zimmer Biomet Robotics NYSE: ZBH (formerly, Medtech Surgical Inc.), a manufacturer of musculoskeletal products, serving most recently as the Commercial Vice President of Americas for the ROSA Robotics Platform and Zimmer Biomet mymobility. In that role, Mr. Shaw's responsibilities included managing new strategic business units and building new corporate training organization for business units. From February 2014 to July 2014 Mr. Shaw was a regional sales director for Salesforce.com (NYSE: CRM), a cloud-based software-as-a-service company, where he managed the Central Region Small Business Team.- William Shaw是我们的首席商务官，自2019年5月6日起担任该职位。从2014年7月到加入公司，Shaw先生在Zimmer Biomet Robotics NYSE:ZBH（前身为Medtech Surgical Inc.）担任不同职位，该公司是一家肌肉骨骼产品制造商，最近担任Rosa Robotics平台和Zimmer Biomet MyMobility的美洲商业Vice President。在那个职位上，Shaw先生的职责包括管理新的战略业务单元和为业务单元建立新的企业培训组织。从2014年2月到2014年7月，他曾担任Salesforce.com公司（纽约证券交易所代码:CRM）（基于云的软件即服务公司）的区域销售董事，在那里他曾管理中部地区小企业团队。
- William Shaw is our Chief Commercial Officer, and he has served in that position since May 6 2019. From July 2014 until joining the Company, Mr. Shaw worked in different roles at Zimmer Biomet Robotics NYSE: ZBH (formerly, Medtech Surgical Inc.), a manufacturer of musculoskeletal products, serving most recently as the Commercial Vice President of Americas for the ROSA Robotics Platform and Zimmer Biomet mymobility. In that role, Mr. Shaw's responsibilities included managing new strategic business units and building new corporate training organization for business units. From February 2014 to July 2014 Mr. Shaw was a regional sales director for Salesforce.com (NYSE: CRM), a cloud-based software-as-a-service company, where he managed the Central Region Small Business Team.
- John F. Glenn
John F. Glenn.Glenn自2008年1月起担任公司首席财务官。Glenn于2004年10月到2007年12月担任Cholestech Corporation（一家心脏病和炎性疾病风险评估和治疗监管诊断工具供应商）首席财务官、金融副总裁、风险官和秘书。Glenn于1999年到2004年1月担任Invivo Corporation（一家医疗设备公司）首席财务官和金融副总裁。Glenn持有University of Nevada工商管理理学学士学位以及Santa Clara University工商管理硕士学位。
John F. Glenn is our Chief Financial Officer and Secretary, and he has served in that position since August 13 2018. Prior to joining us, Mr. Glenn was a consultant to biotechnology and medical device companies. From 2016 to 2017 Mr. Glenn served as the Chief Financial Officer of Sonendo Inc., a privately held, venture-backed company developing technology for dental root canal therapy. In that role, Mr. Glenn worked on strategic initiatives, including corporate development and financing. From 2015 to 2016 Mr. Glenn served as the Chief Financial Officer of Armetheon, Inc., a privately held biopharmaceutical company. From January 2008 to January 2014 Mr. Glenn served as the Chief Financial Officer of Solta Medical, Inc. Nasdaq: SLTM, where he assisted in the strategic acquisition by Valeant Pharmaceuticals International, Inc. of this then-Nasdaq-listed company that designed, developed, manufactured and marketed energy-based medical device systems for aesthetic applications. Mr. Glenn holds a Bachelor of Science degree in Business Administration from the University of Nevada and from the University of Santa Clara, a Master of Business Administration.- John F. Glenn.Glenn自2008年1月起担任公司首席财务官。Glenn于2004年10月到2007年12月担任Cholestech Corporation（一家心脏病和炎性疾病风险评估和治疗监管诊断工具供应商）首席财务官、金融副总裁、风险官和秘书。Glenn于1999年到2004年1月担任Invivo Corporation（一家医疗设备公司）首席财务官和金融副总裁。Glenn持有University of Nevada工商管理理学学士学位以及Santa Clara University工商管理硕士学位。
- John F. Glenn is our Chief Financial Officer and Secretary, and he has served in that position since August 13 2018. Prior to joining us, Mr. Glenn was a consultant to biotechnology and medical device companies. From 2016 to 2017 Mr. Glenn served as the Chief Financial Officer of Sonendo Inc., a privately held, venture-backed company developing technology for dental root canal therapy. In that role, Mr. Glenn worked on strategic initiatives, including corporate development and financing. From 2015 to 2016 Mr. Glenn served as the Chief Financial Officer of Armetheon, Inc., a privately held biopharmaceutical company. From January 2008 to January 2014 Mr. Glenn served as the Chief Financial Officer of Solta Medical, Inc. Nasdaq: SLTM, where he assisted in the strategic acquisition by Valeant Pharmaceuticals International, Inc. of this then-Nasdaq-listed company that designed, developed, manufactured and marketed energy-based medical device systems for aesthetic applications. Mr. Glenn holds a Bachelor of Science degree in Business Administration from the University of Nevada and from the University of Santa Clara, a Master of Business Administration.